PIRFETAB 801mg Tablet 10’s

Description

PIRFETAB 801mg Tablet is an antifibrotic medicine used to help slow the progression of certain lung conditions that cause scarring in the lungs, especially idiopathic pulmonary fibrosis (ipf). ipf is a chronic, progressive disease in which normal lung tissue becomes stiff and scarred over time, making it harder to breathe and reducing the lungs’ ability to transfer oxygen into the blood. PIRFETAB 801mg Tablet does not cure pulmonary fibrosis, and it does not reverse established scarring, but it can help reduce the rate at which lung function declines in appropriate patients. because fibrotic lung disease can gradually worsen and significantly affect quality of life, medicines like PIRFETAB 801mg Tablet are often prescribed as part of a long-term treatment plan under specialist supervision.

although the exact mechanism is not fully understood, PIRFETAB 801mg Tablet is thought to work by reducing the activity of multiple pathways involved in inflammation and fibrosis. it may decrease the production of substances in the body that promote scar tissue formation, such as certain growth factors and inflammatory mediators. by dampening these signals, the medicine may help limit the excessive buildup of collagen and other fibrous tissue in the lungs. this multi-target effect is one reason PIRFETAB 801mg Tablet is considered an antifibrotic agent rather than a simple symptom reliever.

this medicine is typically intended for adults diagnosed with ipf or other selected fibrosing lung conditions where a specialist believes antifibrotic therapy may be beneficial. it is not meant for sudden breathing problems, acute asthma attacks, bronchospasm, or emergency shortness of breath. treatment usually requires regular follow-up, as patients may need monitoring of liver function, symptom changes, oxygen levels, and possible side effects. a healthcare professional should always decide whether PIRFETAB 801mg Tablet is suitable, especially because the medicine can interact with other drugs and may not be appropriate for people with certain liver, kidney, or stomach conditions.

in addition to helping slow disease progression, PIRFETAB 801mg Tablet may also be used in carefully selected situations related to lung fibrosis where the clinical goal is to preserve lung function for as long as possible. since fibrotic lung diseases vary greatly from person to person, the overall treatment plan may also include smoking cessation, vaccinations, pulmonary rehabilitation, oxygen therapy when needed, and management of reflux or other contributing conditions. patients should understand that benefit is usually gradual and preventive in nature rather than immediately noticeable.

ingredients

• PIRFETAB 801mg Tablet: this is the active ingredient responsible for the antifibrotic effect. it helps slow the biological processes that lead to lung scarring and progressive loss of lung function.
• tablet or capsule excipients: depending on the manufacturer, the product may contain inactive ingredients such as fillers, binders, disintegrants, coating agents, and lubricants. these help maintain tablet stability, allow proper swallowing, and support consistent drug release.
• film coating components: some formulations include coating materials that improve handling, reduce moisture exposure, and make the medicine easier to swallow.

key uses

• idiopathic pulmonary fibrosis (ipf): PIRFETAB 801mg Tablet is used to help slow the decline in lung function in adults with ipf, a progressive condition that causes irreversible lung scarring.
• selected progressive fibrosing interstitial lung diseases: in some clinical settings, specialists may consider it for certain fibrosing lung diseases where ongoing scarring is a major feature, depending on local approvals and clinical judgment.
• supportive long-term disease management: the medicine is used as part of a broader strategy to preserve respiratory function, reduce disease progression, and support quality of life over time.

how to use

PIRFETAB 801mg Tablet should be taken exactly as directed by a healthcare professional. it is usually taken by mouth with food to reduce stomach upset and improve tolerability. taking it with meals is important because this medicine can otherwise cause nausea, indigestion, or loss of appetite. patients are often started on a lower amount and then gradually increased over time so the body can adjust more comfortably. the schedule and formulation may vary, so it is important to follow the instructions on the prescription label or from the treating specialist rather than changing the dose on your own.

for best results, take the medicine consistently at the same times each day. swallow tablets whole with water unless a pharmacist or doctor has told you otherwise. do not crush, chew, or alter the tablets unless specifically instructed, because doing so may affect how the medicine is tolerated or absorbed. if the medicine causes sun sensitivity, patients should take extra precautions outdoors, including protective clothing, sunscreen, and avoiding prolonged sun exposure. regular laboratory monitoring may be needed, especially at the beginning of treatment and during dose adjustments.

if you have trouble tolerating the medicine, do not stop it suddenly without speaking to your healthcare provider. side effects are sometimes managed by adjusting the schedule, ensuring it is taken with food, or temporarily pausing treatment under medical supervision. because PIRFETAB 801mg Tablet is intended for long-term management, adherence is important even if you do not feel immediate benefit. always keep scheduled follow-ups so your clinician can assess whether the medicine is helping and whether any safety monitoring is needed.

safety information

• warnings: PIRFETAB 801mg Tablet can cause liver-related problems, including elevated liver enzymes and, rarely, serious liver injury. your doctor may order blood tests to check liver function before and during treatment. it may also cause photosensitivity, so sunlight and tanning beds should be avoided or minimized. report yellowing of the skin or eyes, dark urine, severe fatigue, persistent nausea, or right-sided abdominal pain immediately. if you develop a severe skin rash, blistering, or signs of an allergic reaction, seek medical help right away.
• side effects: common side effects include nausea, stomach discomfort, indigestion, decreased appetite, diarrhea, tiredness, headache, dizziness, and rash. some people also experience vomiting, weight loss, or sensitivity to sunlight. more serious side effects can include significant liver injury, severe skin reactions, shortness of breath that worsens unexpectedly, or signs of infection or weakness that require prompt medical review.
• precautions: use caution if you have liver disease, kidney problems, a history of severe stomach or intestinal issues, or if you are sensitive to sunlight. people with a history of drug allergies should inform their clinician before starting. this medicine may not be suitable for everyone with severe hepatic impairment or certain unstable medical conditions. older adults may be more vulnerable to side effects and may require closer monitoring.
• pregnancy/breastfeeding: safety data in pregnancy are limited, and PIRFETAB 801mg Tablet should only be used if the expected benefit clearly outweighs possible risk. if you are pregnant, planning pregnancy, or become pregnant during treatment, contact your healthcare provider promptly. it is not well established whether PIRFETAB 801mg Tablet passes into breast milk, so breastfeeding should be discussed with a qualified clinician before use.
• interactions: PIRFETAB 801mg Tablet may interact with medicines that affect liver enzymes, especially cyp1a2 inhibitors or inducers, which can alter its levels in the body. some interacting medicines may raise the risk of side effects, while others may reduce effectiveness. tell your doctor about all prescription drugs, over-the-counter products, vitamins, and herbal supplements. alcohol may worsen stomach irritation or liver strain and should be used cautiously, if at all, unless a healthcare professional says it is acceptable.

additional information

• storage: store PIRFETAB 801mg Tablet at room temperature in a dry place, away from excess heat, moisture, and direct light. keep the medicine in its original container if possible, and always out of reach of children and pets. do not store it in the bathroom unless the product label specifically allows it.
• missed dose: if you miss a dose, take it as soon as you remember if it is not almost time for the next dose. if it is close to the next scheduled dose, skip the missed dose and return to your normal schedule. do not double up to make up for a missed dose unless your healthcare professional specifically instructs you to do so.
• overdose: taking too much PIRFETAB 801mg Tablet may increase the risk of severe nausea, vomiting, dizziness, fatigue, low blood pressure, liver problems, or other serious effects. if an overdose is suspected, seek emergency medical attention or contact poison control immediately. bring the medicine package with you if possible, so healthcare staff can identify the product and amount taken.
• habit forming: no. PIRFETAB 801mg Tablet is not considered habit-forming and does not cause dependence or addiction. however, it should still be taken exactly as prescribed because stopping or changing therapy without medical advice may reduce its intended benefit.

frequently asked questions

this information is for educational purposes only and should not be considered medical advice. always consult a qualified healthcare professional before use.